A Health Economic Trial in Adult Patients Undergoing Ileostomy Reversal MA402S23B501
Completed · Phase 4
Conditions studied: Retraction of Colostomy
In brief
This study is designed to compare the standard of care against EXPAREL (bupivacaine liposome injectable suspension) to determine if total opioid consumption is reduced when using EXPAREL, therefore possibly reducing total hospitalization costs.
Key facts
- Study ID
- NCT01509638
- Run by
- Pacira Pharmaceuticals, Inc
- People needed
- 47
- Starts
- 2012-03-01
- Expected to finish
- 2012-10-01
- Last updated by the study team
- 2014-03-06
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Male or female, 18 years of age or older.
- Patients scheduled to undergo ileostomy reversal.
- Ability to provide informed consent, adhere to study visit schedule, and complete all assessments.
You may not qualify if…
- Patients with a history of hypersensitivity or idiosyncratic reactions or intolerance to any local anesthetic, opioid, or propofol.
- Patients who abuse alcohol or other drug substance.
- Patients with severe hepatic impairment.
- Patients currently pregnant or who may become pregnant during the course of the study or who are unwilling to use acceptable means of contraception for at least one month before and one month after dosing.
- Patients with any psychiatric, psychological, or other condition that the Investigator feels may make the patient an inappropriate candidate for this clinical study.
- Patients who have participated in an EXPAREL study within the last 30 days.
- Patients who have received an investigational drug within 30 days prior to study drug administration, or planned administration of another investigational product or procedure during the patient's participation in this study.
- In addition, the patient will be ineligible if he/she meets the following criteria during surgery:
- Patients who have any concurrent surgical procedure.
- Patients who receive intraoperative administration of opioids (other than fentanyl or analogs) or any other analgesic, local anesthetics, or anti-inflammatory agents.
- Patients who receive Entereg(R).
Where it is running
- Cleveland Clinic Florida — Weston, Florida, United States
- Cleveland Clinic Ohio — Beachwood, Ohio, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.